Model/Assay
|
Assay System
|
Disease area
|
Sander-Cramer assay for evaluation of spermicidal activity
|
In vitro
|
Contraception |
Assay for vaginal contraception in Rabbit
|
In vivo
|
Contraception |
Anti-implantation assay for the contraceptive agent development
|
In vivo
|
Reproductive Health Research
|
Hyperandrogenized polycystic ovary syndrome (PCOS) assay
|
In vivo
|
Reproductive Health Research
|
Granulosa cells steroidogenesis assay
|
In vivo
|
Reproductive Health Research
|
Autologous/ heterologous Endometriosis assay
|
In vivo
|
Reproductive Health Research
|
Evaluation of Anti-proliferative activity against human BPH-stromal primary cells
|
In vitro
|
Benign Prostatic Hyperplasia
|
In vivo assay for anti-BPH activity in rat model
|
In vivo
|
Benign Prostatic Hyperplasia
|
Anti-spermatogenic activity in rats
|
In vivo
|
Contraception
|
Wound healing assay
|
In vitro
|
|
Migration and invasion assays
|
In vitro
|
Cancer
|
DMBA-induced mammary tumor model
|
In vivo
|
Breast cancer
|
Topoisomerase inhibition assay |
In vitro
|
Cancer
|
Anti-proliferation Assay in Primary cell lines
|
In vitro screening for the compounds anti-proliferation activity
|
Cancer
|
Apoptosis assay in primary cells/ tumors
-To evaluate the anti-cancerous properties of a particular compound using apoptosis assay |
In vitro/ In vivo
|
Cancer
|
DNMT, HDAC, HAT activity assays
- Epigenetic assays for aging and anti-cancer research.
Assays being used to evaluate the epigenetic targets of novel compounds in mammalian cell lines. The major epigenetic targets are DNMTs, HATs and HDACs.
|
In vitro
|
|
Telomerase assay |
In vitro |
Cancer, Aging
|
Chromatin Immuno Precipitation (ChIP) assay- For DNA-protein interaction studies |
In vitro |
Cancer / Male Reproduction/Neurobiology |
Comet Assay
-For DNA damage |
In vitro |
Cancer, Male reproduction |
Transcription assay |
In vitro |
Cancer, Male reproduction |
Clonogenic assay |
In vitro |
Cancer |
Proteasome inhibition assay –For screening of proteasome inhibitors
|
In vitro |
Cancer / Male Reproduction |
Mammalian two hybrid assay- Cellular function |
In vitro |
Cancer / Male Reproduction |
Flowcytometric TUNEL assay-DNA damage, apoptosis |
In vitro |
Cancer / Male Reproduction |
PMN Phagocytosis assay- For screening of Phagocytosis |
In vitro |
Cancer / Male Reproduction |
Flurometry based autophagy assay- For screening of Autophagy |
In vitro |
Cancer / Male Reproduction |
Middle cerebral artery occlusion- For Screening of neuroprotective activity |
In vitro |
Neurobiology |
Luciferase reporter assay- For evaluation of Transcriptional activity |
In vitro |
Cancer / Male Reproduction/Neurobiology |
Neonatal SD rats for calvarial osteoblast cell isolation.
-Use for assessing alkaline phosphatase activity as a measure of osteoblast differentiation and alizarin staining for osteoblast mineralization |
In vitro |
Osteoporosis/ Bone diseases |
Peak bone mass measurements- Rats administered with compound showing promising in vitro activity. Treatment for one month, autopsied and bones and serum used for evaluating bone formation and resorption parameters. |
In vitro |
Osteoporosis/ Bone diseases |
Adult SD osteopenic rat model. -Rats ovariectomized and left for a period of three months to develop osteopenia. Following this, osteopenic rats administered compound for three months, autopsied and bones and serum used for evaluating bone formation and resorption parameters |
In vitro |
Osteoporosis/ Bone diseases |
Adult Ovariectomized Balb/c mice model. Mice ovariectomized and administered compound for one month, autopsied and bones and serum used for evaluating bone formation and resorption parameters |
In vitro |
Osteoporosis/ Bone diseases |
Bone marrow culture from adult SD rats-For osteogenic differentiation |
Ex vivo |
Osteoporosis/ Bone diseases |
Bone marrow culture from female Balb/c mice-For osteoclast differentiation |
Ex vivo |
Osteoporosis/ Bone diseases |
* Minimum Quantity of the compound required, running cost of the assay and time required for the assay shall be communicated on request